UA66809C2 - Спосіб лікування гіперглікемії похідною тіазолідиндіону - Google Patents

Спосіб лікування гіперглікемії похідною тіазолідиндіону

Info

Publication number
UA66809C2
UA66809C2 UA2000042049A UA00042049A UA66809C2 UA 66809 C2 UA66809 C2 UA 66809C2 UA 2000042049 A UA2000042049 A UA 2000042049A UA 00042049 A UA00042049 A UA 00042049A UA 66809 C2 UA66809 C2 UA 66809C2
Authority
UA
Ukraine
Prior art keywords
hyperglycaemia
treatment
mammal
pharmaceutically acceptable
need
Prior art date
Application number
UA2000042049A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Робін Едвін Букінгем
Стефен Елістер Сміт
Original Assignee
Смітклайн Бічам Плс
Смитклайн Бичам Плс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смітклайн Бічам Плс, Смитклайн Бичам Плс filed Critical Смітклайн Бічам Плс
Publication of UA66809C2 publication Critical patent/UA66809C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
UA2000042049A 1997-10-13 1998-10-12 Спосіб лікування гіперглікемії похідною тіазолідиндіону UA66809C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721692.3A GB9721692D0 (en) 1997-10-13 1997-10-13 Novel treatment
PCT/GB1998/003067 WO1999018944A1 (fr) 1997-10-13 1998-10-12 Utilisation de thiazolidinediones pour le traitement de l'hyperglycemie

Publications (1)

Publication Number Publication Date
UA66809C2 true UA66809C2 (uk) 2004-06-15

Family

ID=10820481

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2000042049A UA66809C2 (uk) 1997-10-13 1998-10-12 Спосіб лікування гіперглікемії похідною тіазолідиндіону

Country Status (24)

Country Link
EP (1) EP1023057A1 (fr)
JP (1) JP2001519383A (fr)
KR (1) KR20010024482A (fr)
CN (1) CN1281358A (fr)
AP (1) AP1223A (fr)
AU (1) AU9547198A (fr)
BG (1) BG104405A (fr)
BR (1) BR9815220A (fr)
CA (1) CA2305289A1 (fr)
CZ (1) CZ20001298A3 (fr)
EA (1) EA200000418A1 (fr)
GB (1) GB9721692D0 (fr)
HR (1) HRP20000256A2 (fr)
HU (1) HUP0003673A3 (fr)
ID (1) ID24439A (fr)
IL (1) IL135515A0 (fr)
NO (1) NO20001897L (fr)
OA (1) OA11519A (fr)
PL (1) PL339804A1 (fr)
SK (1) SK5322000A3 (fr)
TR (1) TR200000957T2 (fr)
UA (1) UA66809C2 (fr)
WO (1) WO1999018944A1 (fr)
YU (1) YU28700A (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
SK1012001A3 (en) * 1998-07-21 2001-08-06 Smithkline Beecham Plc Use of glucose uptake enhancer for reducing apoptosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
CZ20001298A3 (cs) 2001-08-15
YU28700A (sh) 2003-10-31
TR200000957T2 (tr) 2000-08-21
OA11519A (en) 2004-02-09
KR20010024482A (ko) 2001-03-26
EA200000418A1 (ru) 2000-10-30
NO20001897D0 (no) 2000-04-12
AP2000001788A0 (en) 2000-06-30
HUP0003673A2 (hu) 2001-10-28
CN1281358A (zh) 2001-01-24
JP2001519383A (ja) 2001-10-23
ID24439A (id) 2000-07-20
AU9547198A (en) 1999-05-03
WO1999018944A1 (fr) 1999-04-22
AP1223A (en) 2003-11-13
BG104405A (en) 2000-12-29
HUP0003673A3 (en) 2001-12-28
NO20001897L (no) 2000-06-09
GB9721692D0 (en) 1997-12-10
BR9815220A (pt) 2000-11-14
EP1023057A1 (fr) 2000-08-02
PL339804A1 (en) 2001-01-02
CA2305289A1 (fr) 1999-04-22
IL135515A0 (en) 2001-05-20
SK5322000A3 (en) 2000-09-12
HRP20000256A2 (en) 2000-12-31

Similar Documents

Publication Publication Date Title
AU3215597A (en) Method of inhibiting fibrosis with a somatostatin agonist
SG127714A1 (en) Method of treating metabolic disorders, especiallydiabetes, or a disease or condition associated wi th diabetes
BG105568A (en) Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent
EP1127579A3 (fr) Procedé permettant d'accroitre la biodisponibilité des compositions pharmaceutiques administrées par voie orale
NZ514574A (en) Novel method of treatment
LU91138I2 (fr) Glulisine d'insuline et ses dérivés pharmaceutiquement acceptables.
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
ZA989744B (en) Method for administering acylated insulin.
CA2329004A1 (fr) Combinaison d'un sensibilisateur a l'insuline et d'un anorexigene pour le traitement ou la prevention du diabete
MY121517A (en) Anticonvulsant derivatives useful in reducing blood glucose levels
WO1999004772A3 (fr) Levobupivacine et son utilisation
CA2339218A1 (fr) Procedes et compositions servant a augmenter la sensibilite a l'insuline
CA2253130A1 (fr) Medicament pour traiter l'obesite et ameliorer le metabolisme lipidique
BG104059A (en) Diabetes treatment with rosiglytazone and insulin
CA2280773A1 (fr) Procedes d'administration d'amifostine
BG104058A (en) Diabetes treatment with thiazolydindion and sulphonylurea
BG101884A (en) Salts of the clavulanic acid
YU28700A (sh) Upotreba potencijatora osetljivosti na insulin u proizvodnji leka za lečenje hiperglikemije
BG104139A (en) Diabetes treatment with thizolidindion and sulphonylurea
CA2234936A1 (fr) Composition pour traiter une affection intestinale inflammatoire par l'administration de n-acetylglucosamine par le colon et traitement connexe
NZ503862A (en) Use of insulin sensitisers (especially thiazolidinediones) for the treatment of hyperglycaemia
CA2185794A1 (fr) Medicaments destines a soulager les effets secondaires provoques par des immunodepresseurs
AU2002236587A1 (en) Compositions for adhesion prevention
MX9604692A (es) Derivados de quinoxalina para el tratamiento de tinnitus.
GB9526331D0 (en) Novel method